Why CROs need to rethink monitoring, not reduce it.
For years, the conversation around monitoring has been framed in terms of cost.
- How many visits are we doing?
- How much SDV is required?
- Where can we reduce effort without increasing risk?
Those questions made sense in a model where monitoring focused primarily on coverage, ensuring that enough review activity occurred to maintain quality.
But that model no longer holds.
Sponsors are reducing monitoring budgets while simultaneously increasing expectations for oversight, traceability, and data reliability. CROs are expected to do more with less while also explaining, justifying, and defending every decision.
In that environment, treating monitoring as a cost problem is no longer sufficient. Monitoring isn’t just a cost center. It’s a margin lever.
The Problem with Cost-Driven Thinking
When monitoring is viewed primarily through a cost lens, the instinct is to reduce activity.
Fewer visits. Less SDV. Leaner teams.
But without a risk-based framework guiding those reductions, the result isn’t efficiency; it’s inconsistency.
Important signals can be missed. Oversight becomes uneven across sites and studies. Decisions are harder to justify when challenged by Sponsors or inspectors.
In trying to reduce costs, organizations often increase risk. That’s why many early RBQM initiatives stalled. They focused on doing less, rather than doing what matters most.
The Shift: From Volume to Precision
What RBQM introduces isn’t simply a reduction in monitoring; it’s a reallocation of effort.
Instead of asking how much monitoring is needed, the question becomes:
Where does monitoring create the most value?
That shift changes how oversight is executed. CRA time is no longer distributed evenly across sites. It’s focused where risk is highest, and impact is greatest. Monitoring becomes targeted, dynamic, and continuously informed by data.
This isn’t about removing oversight, but rather making oversight more precise.
What This Means for CRO Economics
When monitoring is aligned to risk, the operational impact becomes clear.
Low-value activity is reduced, not eliminated arbitrarily, but replaced with higher-value work. CRAs spend less time on routine review and more time addressing meaningful issues. Site engagement becomes more purposeful. Interventions are earlier and more targeted.
Over time, that shift changes the economics of delivery.
Utilization improves. Teams are less reactive. Delivery becomes more predictable. And importantly, CROs become less dependent on discounting to remain competitive in bids.
Because they’re no longer competing on volume. They’re competing on effectiveness.
Why This Is a Commercial Advantage
Sponsors are not looking for CROs that do the most monitoring. They’re looking for CROs that can demonstrate:
- Why oversight decisions were made
- How monitoring effort was allocated
- What actions were taken in response to risk
In other words, they’re evaluating the quality of oversight, not the quantity. CROs that can show this clearly have an advantage, not just in execution, but in positioning. They’re easier to trust. Easier to defend. Easier to expand.
The Takeaway
Monitoring isn’t going away, but the model behind it is changing.
CROs that continue to treat monitoring as a cost to be reduced will struggle to balance efficiency with quality. CROs that treat it as a margin lever, something to be optimized, not minimized, will be better positioned to:
- Improve delivery performance
- Protect profitability
- Differentiate in competitive bids
